文献速递外周动脉疾病

股浅动脉球囊扩张后夹层形态与通畅率结局

Angiographic Dissection Patterns and Patency Outcomes After Balloon Angioplasty for Superficial Femoral Artery Disease.
PubMed 文献 · J Endovasc Ther · 2017-03-20

该多中心回顾性研究分析748处股浅动脉原发病变,按改良冠脉分型将球囊扩张后夹层分为7型,严重夹层(C型及以上)占42%。仅球囊治疗的193处病变2年随访显示,严重夹层组通畅率更低且靶病变血运重建率更高;小参考血管直径、长病变及慢性完全闭塞是严重夹层的独立预测因素。

要点

  • 股浅动脉球囊扩张后严重夹层(C型及以上)发生率达42%
  • 严重夹层与2年通畅率降低及靶病变血运重建增加相关
  • 小血管直径<5 mm、病变长度>15 cm及慢性完全闭塞预测严重夹层

核心结论

  • 股浅动脉球囊扩张后42%的病例出现严重夹层,严重夹层在仅用球囊治疗的病变中可影响长期通畅率。

研究设计与样本

  • 回顾性多中心分析纳入621例患者(平均年龄72.8±9.5岁,414例男性)的748处症状性股浅动脉原发病变,均接受血管内治疗。
  • 夹层按改良冠脉A-F分型分为7型,C型及以上定义为严重夹层;555处(74.2%)病变因残余狭窄>30%或限流性夹层植入镍钛支架。
  • 仅球囊治疗的193处病变(25.8%)纳入2年随访,分析主要通畅率和临床驱动的靶病变血运重建。

主要发现

  • 无夹层占16%(120/748),A型占19%(142/748),B型占23%(172/748)。
  • C型及以上占42%,其中D型最常见(180/748,24%),C型37/748(5%),E型67/748(9%),F型30/748(4%)。
  • 补救性支架植入率随夹层严重程度增加而升高。
  • 2年随访时,严重夹层组(C-F型)通畅率显著低于非严重组(无夹层及A、B型)(p<0.001),临床驱动靶病变血运重建显著更高(p<0.001)。
  • 严重夹层是再狭窄的显著危险因素,再狭窄率从C型至F型逐步升高。

关键数值与推荐

  • 多因素分析显示小参考血管直径<5 mm(p=0.001)、病变长度>15 cm(p=0.001)和慢性完全闭塞(p<0.001)是严重夹层的独立预测因素。
  • 亚组分析中小参考直径血管及TASC II C、D级病变的严重夹层发生率更高。

临床怎么用

  • 球囊扩张后应仔细评估夹层形态,C型及以上严重夹层需警惕远期通畅率下降。
  • 对 small reference vessel diameter <5 mm、病变长度>15 cm或慢性完全闭塞的股浅动脉病变,应预判严重夹层风险并考虑补救性支架。

局限性

  • 回顾性研究设计。
  • 仅球囊治疗的193处病变进入2年随访分析,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the angiographic dissection patterns after balloon angioplasty for superficial femoral artery (SFA) lesions, the clinical outcome associated with each dissection pattern, and the predictive factors for severe dissection. METHODS: A retrospective, multicenter analysis examined 621 patients (mean age 72.8±9.5 years; 414 men) with 748 symptomatic de novo SFA lesions treated with endovascular therapy. Vessel dissection after the initial balloon angioplasty procedure was graded into 7 types according to a modified version of the coronary artery classification types A to F. Severe vessel dissection patterns were defined as type C or higher. Nitinol stent implantation was performed in 555 (74.2%) lesions for residual stenosis >30% or flow-limiting dissection; 193 lesions (25.8%) were treated with balloon angioplasty only. To determine the clinical outcomes associated with each dissection pattern and identify predictive factors for severe dissection, 2-year follow-up data for the 193 lesions treated with balloon angioplasty only were analyzed for primary patency and clinically driven target lesion revascularization (TLR). RESULTS: No dissection was found in 16% (120/748) of lesions, and types A and B dissections were seen in 19% (142/748) and 23% (172/748), respectively. Dissection grades above type C were observed in 42% of cases, most frequently type D (180/748, 24%) and less often type C (37/748, 5%), type E (67/748, 9%), and type F (30/748, 4%). The bailout stent implantation rate increased according to dissection severity. At up to 2 years, the severe dissection group (types C-F) showed a significantly lower patency rate (p<0.001) and higher clinically driven TLR (p<0.001) compared to the nonsevere group (no dissection and types A and B dissections). Severe dissection was a significant risk factor for restenosis, which rose progressively from types C to F. Multivariate analysis identified a small reference vessel diameter <5 mm (p=0.001), lesion length >15 cm (p=0.001), and chronic total occlusion (p<0.001) as independent predictors of severe dissection. In subgroup analysis, vessels with a small reference diameter and TASC II C and D lesions had a higher prevalence of severe dissection. CONCLUSION: Severe dissection was found in 42% of cases after PTA. A small vessel diameter and/or TASC II C/D lesions were related to a high incidence of dissection. Severe dissection during procedures employing balloon angioplasty only could affect long-term patency.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Fujihara M, Takahara M, Sasaki S, et al. Angiographic Dissection Patterns and Patency Outcomes After Balloon Angioplasty for Superficial Femoral Artery Disease. J Endovasc Ther. 2017. PMID: 28351208. doi:10.1177/1526602817698634

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。